List of Lek (pharmaceutical company) patents

Patent 7153970 was granted and assigned to Lek (pharmaceutical company) on December, 2006 by the United States Patent and Trademark Office.

Patent 10357431 was granted and assigned to Lek (pharmaceutical company) on July, 2019 by the United States Patent and Trademark Office.

Patent 7534870 was granted and assigned to Lek (pharmaceutical company) on May, 2009 by the United States Patent and Trademark Office.

Patent 7585496 was granted and assigned to Lek (pharmaceutical company) on September, 2009 by the United States Patent and Trademark Office.

Patent 8980585 was granted and assigned to Lek (pharmaceutical company) on March, 2015 by the United States Patent and Trademark Office.

Patent 9447188 was granted and assigned to Lek (pharmaceutical company) on September, 2016 by the United States Patent and Trademark Office.

Patent 8648175 was granted and assigned to Lek (pharmaceutical company) on February, 2014 by the United States Patent and Trademark Office.

Patent 8404870 was granted and assigned to Lek (pharmaceutical company) on March, 2013 by the United States Patent and Trademark Office.

Patent 8044086 was granted and assigned to Lek (pharmaceutical company) on October, 2011 by the United States Patent and Trademark Office.

Patent 8471045 was granted and assigned to Lek (pharmaceutical company) on June, 2013 by the United States Patent and Trademark Office.

Patent 9512097 was granted and assigned to Lek (pharmaceutical company) on December, 2016 by the United States Patent and Trademark Office.

Patent 9732053 was granted and assigned to Lek (pharmaceutical company) on August, 2017 by the United States Patent and Trademark Office.

Patent 8183397 was granted and assigned to Lek (pharmaceutical company) on May, 2012 by the United States Patent and Trademark Office.

Patent 10913985 was granted and assigned to Lek (pharmaceutical company) on February, 2021 by the United States Patent and Trademark Office.

Patent 8389695 was granted and assigned to Lek (pharmaceutical company) on March, 2013 by the United States Patent and Trademark Office.

Patent 8053444 was granted and assigned to Lek (pharmaceutical company) on November, 2011 by the United States Patent and Trademark Office.

Patent 9376397 was granted and assigned to Lek (pharmaceutical company) on June, 2016 by the United States Patent and Trademark Office.

Patent 10913984 was granted and assigned to Lek (pharmaceutical company) on February, 2021 by the United States Patent and Trademark Office.

Patent 9359617 was granted and assigned to Lek (pharmaceutical company) on June, 2016 by the United States Patent and Trademark Office.

Patent 9359385 was granted and assigned to Lek (pharmaceutical company) on June, 2016 by the United States Patent and Trademark Office.

Patent 9562082 was granted and assigned to Lek (pharmaceutical company) on February, 2017 by the United States Patent and Trademark Office.

Patent 8410285 was granted and assigned to Lek (pharmaceutical company) on April, 2013 by the United States Patent and Trademark Office.

Patent 7968727 was granted and assigned to Lek (pharmaceutical company) on June, 2011 by the United States Patent and Trademark Office.

Patent 8247566 was granted and assigned to Lek (pharmaceutical company) on August, 2012 by the United States Patent and Trademark Office.

Patent 9499857 was granted and assigned to Lek (pharmaceutical company) on November, 2016 by the United States Patent and Trademark Office.